Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line.
about
Mutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR AssayFluid biopsy for solid tumors: a patient's companion for lifelong characterization of their diseaseUsing circulating tumor cells to inform on prostate cancer biology and clinical utilityBlood-based analyses of cancer: circulating tumor cells and circulating tumor DNARapid phenotypic and genomic change in response to therapeutic pressure in prostate cancer inferred by high content analysis of single circulating tumor cellsCirculating tumor microemboli diagnostics for patients with non-small-cell lung cancer.Circulating tumor cells in prostate cancer diagnosis and monitoring: an appraisal of clinical potential.Immunomagnetic nanoscreening of circulating tumor cells with a motion controlled microfluidic system.Circulating tumor cells as emerging tumor biomarkers in lung cancerCirculating Tumor Cells: When a Solid Tumor Meets a Fluid MicroenvironmentMorphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells.Physical biology in cancer. 2. The physical biology of circulating tumor cells.Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications.Recent advances in the molecular characterization of circulating tumor cells.Circulating tumour cells-monitoring treatment response in prostate cancer.Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.Circulating tumor cell technologies.Advancing cancer patient care by integrating circulating tumor cell technology to understand the spatial and temporal dynamics of cancer.Circulating Tumor Cells: Moving Biological Insights into Detection.Monolithic Chip for High-throughput Blood Cell Depletion to Sort Rare Circulating Tumor Cells.Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology.Systems Pharmacology Modeling of Prostate-Specific Antigen in Patients With Prostate Cancer Treated With an Androgen Receptor Antagonist and Down-Regulator.Automated electrorotation shows electrokinetic separation of pancreatic cancer cells is robust to acquired chemotherapy resistance, serum starvation, and EMT.Size-selective collection of circulating tumor cells using Vortex technology.Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell Clusters.Continuous Flow Deformability-Based Separation of Circulating Tumor Cells Using Microfluidic Ratchets.Opportunities and Challenges in Implementation of Multiparameter Single Cell Analysis Platforms for Clinical Translation.
P2860
Q24608051-3E2BC695-80B7-43ED-ABC9-942CDBCD7392Q24623374-F37C13D7-743B-44B5-BE8C-D1CE31105801Q28083261-929BA273-6DB8-4549-87E1-8BB2FEE88CD6Q28239638-00ACFCE8-5507-4C77-8FDF-B666E483B245Q33988851-F9D18EE4-27A0-4CA2-82A1-F560261A42A5Q34093217-35C724B2-C0B6-4D13-BDCE-8209223125CDQ34108738-7D593D74-2BA2-4EBC-BBB6-7C01C8CD02F0Q34308871-C70ED2F6-63DC-49D3-A0B9-3F83D8094A0EQ36287633-AEAA9500-D88D-4CA8-A1B4-D974310CBB0EQ37420868-526D98B9-CCB5-4113-8D43-52ACEC6F3EC3Q37453217-87244BDB-1C05-44DB-89E9-434E18C2CCABQ37575309-5B6B68FC-DA39-42B6-B05B-E05AD97B64CBQ37626062-010FF8E2-3C0C-4EA5-94DD-E3E96C1BF025Q37693504-5D269D1D-72B7-449B-AF6C-E9B6DA687B8BQ38211361-A9A8835E-60F0-487A-B36D-89857C0D4094Q38600919-BBB0A49A-9D92-4997-88A9-799C7E2DDD7CQ38742272-B4EBCFCC-A766-4BE9-83CC-F25B9267068EQ39133502-364D8DF7-B532-46D0-9CE8-F6DAF3CF9137Q41430303-ACB7FA6F-0150-4E02-9B23-06991EF4067FQ41537748-771D8992-7CC4-4D14-8EA3-4E73D135FB1BQ42128647-9A2C96F3-9E7C-4BA4-B215-9344E512A78AQ42763555-04D8F3D4-C8CC-4FEE-B375-F145052C41A0Q44814353-807DA259-C066-4216-AF8F-3DD7A09F0009Q45077599-5C744271-E40B-4BAF-9822-9BBFB9FFE604Q46855168-CAD38973-B59B-4C3C-898A-35561A9FF781Q51492172-9952CDC4-615A-47D6-908B-E32118757C25Q52729352-019E14A1-95F6-4048-8F97-3CAEC7795BA7
P2860
Cytometric comparisons between circulating tumor cells from prostate cancer patients and the prostate-tumor-derived LNCaP cell line.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cytometric comparisons between ...... tumor-derived LNCaP cell line.
@en
Cytometric comparisons between ...... tumor-derived LNCaP cell line.
@nl
type
label
Cytometric comparisons between ...... tumor-derived LNCaP cell line.
@en
Cytometric comparisons between ...... tumor-derived LNCaP cell line.
@nl
prefLabel
Cytometric comparisons between ...... tumor-derived LNCaP cell line.
@en
Cytometric comparisons between ...... tumor-derived LNCaP cell line.
@nl
P2093
P2860
P356
P1433
P1476
Cytometric comparisons between ...... tumor-derived LNCaP cell line.
@en
P2093
Daniel C Lazar
Edward H Cho
Madelyn S Luttgen
Maria Loressa Uson
Melissa Torrey
Mitchell E Gross
Peter Kuhn
Thomas J Metzner
P2860
P304
P356
10.1088/1478-3975/9/1/016002
P577
2012-02-03T00:00:00Z